Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:452-456
Published online before print July 14, 2003, doi: 10.1161/01.CIR.0000080916.84077.C0
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/4/452    most recent
01.CIR.0000080916.84077.C0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traverse, J. H.
Right arrow Articles by Emery, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traverse, J. H.
Right arrow Articles by Emery, R. W.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease

(Circulation. 2003;108:452.)
© 2003 American Heart Association, Inc.


Clinical Investigation and Reports

Clinical, Angiographic, and Interventional Follow-Up of Patients With Aortic-Saphenous Vein Graft Connectors

Jay H. Traverse, MD; Michael R. Mooney, MD; Wesley R. Pedersen, MD; James D. Madison, MD; Thomas F. Flavin, MD; Vibhu R. Kshettry, MD; Timothy D. Henry, MD; Frazier Eales, MD; Lyle D. Joyce, MD; Robert W. Emery, MD

From the Minneapolis Heart Institute at Abbott Northwestern Hospital, Minneapolis, Minn.

Correspondence to Jay H. Traverse, MD, Minneapolis Cardiology Associates, Minneapolis Heart Institute, 920 East 28th Street, Suite 300, Minneapolis, MN 55407. E-mail trave004{at}tc.umn.edu

Received February 5, 2003; revision received April 24, 2003; accepted April 25, 2003.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Background— The use of aortic connectors for proximal saphenous vein bypass graft anastomoses eliminates the need for aortic clamping during coronary artery bypass grafting (CABG) and may reduce the incidence of stroke in the elderly and in patients with severe aortic atherosclerosis.

Methods and Results— We studied 74 consecutive patients who received the Symmetry Bypass System aortic connector at the time of CABG. A total of 131 of 144 proximal vein graft anastomoses were performed with this device. The left internal mammary artery was used in 62 patients, and 61 patients had "off-pump" coronary revascularization. A total of 11 patients were readmitted with chest pain consistent with unstable angina 173±39 days after CABG. Five of the 11 patients had previous in-stent restenosis before CABG. At angiography, 20 saphenous vein bypass grafts containing 19 connectors were found to have severe stenosis (n=12) or occlusion (n=6) and were treated with angioplasty and stenting or medical therapy. Seven of 11 patients were readmitted 76±11 days later with recurrent chest pain and were found to have severe stenosis at the previously stented connector site. Six patients underwent angioplasty followed by brachytherapy. Three of these patients redeveloped chest pain and were readmitted 151±71 days later. Two patients were started on oral Rapamune, and one patient underwent redo-CABG.

Conclusion— Eleven of 74 patients who received aortic connectors at the time of CABG developed symptomatically significant stenosis or occlusion at the connector site shortly after CABG, requiring multiple repeat interventions, including brachytherapy.


Key Words: bypass • stents • restenosis • coronary disease


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Neurological complications are increased in the elderly and in patients with atheromatous or heavily calcified aortas who undergo coronary artery bypass grafting (CABG).1,2 Revascularization without the use of cardiopulmonary bypass ("off-pump") may be particularly beneficial in high-risk patients3 such as the elderly, and it may potentially reduce the incidence of stroke and other neurological complications by avoiding cannulation and cross-clamping of the aorta. Thus, in a retrospective study, Demaria et al1 observed a significant reduction in mortality and the incidence of stroke (6.3% versus 0%) in octogenarians who underwent off-pump CABG compared with revascularization with cardiopulmonary bypass.

However, off-pump bypass surgery still requires the use of aortic side-biting clamps to perform each proximal anastomosis, which may lead to aortic injury4 and the occurrence of stroke in this population. The use of recently developed sutureless aortic-saphenous vein graft connectors may facilitate off-pump coronary revascularization5 and reduce the incidence of stroke and cerebral microemboli in patients by eliminating the need for partial aortic clamping.6 In the present article, we report the clinical, angiographic, and interventional follow-up in the first 74 patients who received aortic connectors at our institution at the time of CABG.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
We investigated the clinical, angiographic, and interventional outcomes of 74 consecutive patients (58 men and 16 women aged 66±2 years) who received the Symmetry Bypass System aortic connector (St Jude Medical, Inc) at the time of CABG at our institution between June 13, 2001, and February 25, 2002. Patient risk factors included hyperlipidemia (n=57), hypertension (n=39), positive family history (n=17), diabetes (n=19), and current or former smoking (n=22). Thirteen of the 74 patients had previously undergone coronary stent implantation and were referred for surgical revascularization because of the development of in-stent restenosis. A total of 131 of 144 proximal vein graft anastomoses were performed with the aortic connector, and the left internal mammary artery was used in 62 patients. A total of 61 patients had their revascularization performed without the use of cardiopulmonary bypass, and 10 patients underwent adjunctive laser transmyocardial revascularization.

There were 10 device failures at the time of implantation in 7 patients. This included 8 instances of excessive bleeding at the connector site and 2 instances of connector thrombosis. There were no perioperative strokes in the group.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowConclusions
down arrowReferences
 
Angiographic and Clinical Follow-Up
Of the 74 patients who received aortic connectors at the time of surgery, 11 were readmitted with chest pain consistent with unstable angina 173±39 days after CABG. Five of these 11 patients had previous in-stent restenosis before CABG. Three patients had elevations in serum troponin on admission consistent with small, non-Q-wave myocardial infarctions. All patients underwent coronary angiography.

A total of 20 vein grafts with 19 connectors were studied at angiography (Table); 12 had severe stenosis at the connector site, and 6 were occluded. Eight patients underwent coronary angioplasty (PTCA) and stenting at the connector site and/or 5 patients underwent PTCA/stenting of their native coronary arteries. One patient underwent stenting at the left internal mammary artery anastomosis. Two patients were treated medically, and one of them was started on oral Rapamune (Wyeth-Ayerst) at a dose of 2 mg/d for 4 weeks. One patient had a small, non-Q-wave myocardial infarction after the procedure (creatine kinase-MB of 15 U; Figure 1)


View this table:
[in this window]
[in a new window]
 
Clinical, Angiographic, and Interventional Follow-Up in 11 Patients Who Developed Severe Stenosis or Occlusion at Their Connector Sites After CABG



View larger version (184K):
[in this window]
[in a new window]
 
Figure 1. Serial angiographic findings in a 74-year-old man without previous in-stent restenosis during his first readmission for chest pain 59 days after CABG. There was a severe stenosis at the connector site in his saphenous vein bypass graft to the ramus intermedius. The patient was treated with angioplasty and stenting. The patient was readmitted 2 months later with recurrent chest pain. Severe in-stent restenosis was present at the previously treated connector site and in the body of the vein graft. The patient was treated with PTCA and stenting at both sites followed by brachytherapy. The patient had a small, non-Q-wave myocardial infarction after the second interventional procedure.

Seven of the 11 patients were readmitted with their second episode of chest pain 76±11 days after their first interventional procedure after CABG (Table). After angiography, 6 patients underwent angioplasty at the connector site followed by brachytherapy (Checkmate, Cordis) with gamma irradiation (Ir-92) and received 18 Gy at 2 mm from the source at 8 connector sites. Two patients underwent PTCA and brachytherapy of their native coronary arteries, and one patient was started on oral Rapamune. One patient had a non-Q-wave myocardial infarction after the procedure (creatine kinase-MB of 102 U; Figure 2).



View larger version (174K):
[in this window]
[in a new window]
 
Figure 2. Serial angiographic findings in a 66-year-old woman with previous in-stent restenosis before CABG during her first admission for chest pain 60 days after CABG. There was severe stenosis at both connector sites, including the saphenous vein graft to the circumflex marginal branch. The patient was treated with angioplasty and stenting and had a small non-Q-wave myocardial infarction after her procedure. The patient returned with recurrent chest pain 83 days later; she had developed severe in-stent restenosis at the connector site. This was successfully treated with PTCA and brachytherapy.

Three of the 11 patients were readmitted with their third episode of chest pain 131±70 days after their second interventional procedure. One patient underwent PTCA of a diagonal branch and was started on Rapamune. A second patient underwent PTCA and brachytherapy at the left internal mammary artery anastomosis. The third patient underwent repeat CABG.

One patient who was managed medically after his first admission for chest pain died from the development of line sepsis after peripheral vascular surgery.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowConclusions
down arrowReferences
 
To our knowledge, this is the largest single-center study to report clinical, angiographic, and interventional follow-up in patients who received aortic-saphenous vein graft connectors. Our findings demonstrate that a significant number of patients present with unstable angina in the first year after CABG secondary to occlusion or severe stenosis at the connector site. Despite successful treatment with PTCA and stenting, many patients required multiple repeat interventions, including brachytherapy, for recurrent in-stent restenosis at the connector site.

The successful long-term treatment of saphenous vein graft disease remains a significant challenge because of the recurrence of significant stenosis after percutaneous intervention or disease progression in other portions of the graft.7 Initial treatment of vein graft disease with stenting seems to result in initial lower rates of target vessel revascularization8 and major cardiac events9 compared with PTCA, although this benefit was not sustained at 3 years.10 The presence of aorto-ostial disease remains a subset of vein graft disease that is significantly problematic to treat, in part because of the high elastic recoil and external compression unique to that location.11 The use of stents in this location is still associated with significant target lesion revascularization at 1 year (approaching 20%) and may be associated with a significant incidence of periprocedural non-Q-wave myocardial infarction.12 In our cohort, we observed a 64% incidence of target lesion revascularization after stenting at the connector site, which is much higher than previously reported at the aorto-ostium in sutured vein grafts. These observations may suggest that the presence of a metallic foreign body at the aorto-ostium or the manipulation and attachment of the vein graft to the connector could result in endothelial injury13 and contribute to a more vigorous injury response after stenting.

The 8 connector sites in 6 patients that developed in-stent restenosis after stenting at the connector site were successfully treated with brachytherapy during their second interventional procedure. However, 4 of these sites in 3 patients redeveloped severe stenosis or occlusion leading to repeat bypass surgery in one patient and initiation of Rapamune in two patients. Previous studies in saphenous vein bypass grafts with in-stent restenosis have demonstrated a 70% reduction in target lesion revascularization with brachytherapy compared with repeat PTCA or stenting.14 The 57% repeat target vessel revascularization is higher than previously reported after brachytherapy in vein grafts, although the number of patients in our group was small and all sites were localized to the aorto-ostium.

We observed the development of symptomatic stenosis or occlusion at 18 connector sites in 11 patients at angiography during their initial on-average presentation of 6 months after CABG. This comprises an attrition rate of 13.7% of a total of 131 connectors placed at the time of surgery. It is possible that this represents a significant underestimation of the true incidence of stenosis or occlusion at the connector site because only symptomatic patients underwent angiography. Previous serial angiographic studies in patients after CABG have demonstrated a significant rate of vein graft attrition in the first month after surgery, with a rate of occlusion between 12% and 13% at 1 month, which increased to 19% to 21% at 1 year.15,16

There have been several preliminary reports describing proximal anastomotic connector systems such as the type used in this study, with angiographic follow-up available in a small group of patients. Wiklund et al17 presented the angiographic findings in the first 10 of 34 patients 4 to 6 months after CABG. There were a total of 10 proximal anastomoses performed with the connector and 14 performed with sutures. At angiographic follow-up, all the patients were asymptomatic, and there was a severe stenosis in one of the sutured vein grafts and one occlusion at the connector site. Calafiore et al18 presented their initial clinical experience in 17 patients who received the aortic anastomotic device (AAD) proximal anastomotic device (Bypass Ltd). Follow-up angiograms in 6 patients performed 48±26 days after CABG revealed that all the proximal anastomoses were widely patent.

There are important technical limitations with these devices that may predispose the vein grafts to develop kinking, which may lead to occlusion of the graft and contribute to the observations reported in this study. Because the connector must deploy the vein graft at a 90-degree takeoff angle from the aorta, the proximal portion of the graft may kink as it courses inferiorly toward the heart. A second technical consideration involves selecting the proper length of vein to graft because the device requires that the proximal anastomosis be performed first. A short segment of vein may be overly stretched when performing the distal anastomosis, whereas too long a segment may result in kinking of the graft.17


*    Conclusions
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*Conclusions
down arrowReferences
 
In a group of 74 patients who received the Symmetry Bypass System aortic connector, 11 patients were readmitted with chest pain consistent with unstable angina on an average of 6 months after CABG because of severe stenosis or occlusion at the connector site. These patients required multiple repeat interventions to treat these sites, with the majority of patients requiring brachytherapy due to restenosis after stenting at the connector. Although these devices may prove to be invaluable in preventing perioperative stroke in the elderly and in patients with severe atheromatous disease of the aorta, they seem to be associated with a relatively high rate of symptomatic stenosis in the first postoperative year.


*    Footnotes
 
Dr Emery serves as a consultant to St Jude Medical, Inc, Maple Grove, Minn.

Presented in part at the 75th Scientific Sessions of the American Heart Association, Chicago, Ill, November 17–20, 2002, and published in abstract form (Circulation. 2002;106(suppl II):II-638).


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowConclusions
*References
 
1. Demaria RG, Carrier M, Fortier S, et al. Reduced mortality and strokes with off-pump coronary artery bypass grafting surgery in octogenarians. Circulation. 2002; 106: I-5–I-10.

2. Ricci M, Karamanoukian HL, Abraham R, et al. Stroke in octogenarians undergoing coronary artery surgery with and without cardiopulmonary bypass. Ann Thorac Surg. 2000; 69: 1471–1475.[Abstract/Free Full Text]

3. Arom KV, Flavin TF, Emery RW, et al. Safety and efficacy of off-pump coronary artery bypass grafting. Ann Thorac Surg. 2000; 69: 704–10.[Abstract/Free Full Text]

4. Eckstein FS, Bonilla LF, Englberger L, et al. The St Jude Medical symmetry aortic connector system for proximal vein graft anastomoses in coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2002; 123: 777–782.[Abstract/Free Full Text]

5. Mack MJ, Dewey TM, Magee MJ. Facilitated anastomosis for reoperative circumflex coronary revascularization on the beating heart through a left thoracotomy. J Thorac Cardiovasc Surg. 2002; 123: 816–817.[Free Full Text]

6. Watters MP, Cohen AM, Monk CR, et al. Reduced cerebral embolic signals in beating heart coronary surgery detected by transcranial Doppler ultrasound. Br J Anaesth. 2000; 84: 629–631.[Abstract/Free Full Text]

7. De Feyer PJ, Van Suylen RJ, De Jaegere PP, et al. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993; 2: 1539–1549.

8. Brener SJ, Ellis SG, Apperson-Hansen C, et al. Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years. Am J Cardiol. 1997; 79: 13–18.[CrossRef][Medline] [Order article via Infotrieve]

9. Savage MP, Douglas JS, Fischman DL. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. N Engl J Med. 1997; 337: 740–747.[Abstract/Free Full Text]

10. Keely EC, Velez CA, O’Neill WW, et al. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001; 38: 659–665.[Abstract/Free Full Text]

11. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? J Am Coll Cardiol. 2001; 38: 150–154.[Abstract/Free Full Text]

12. Bhargava B, Kornowski R, Mehran R, et al. Procedural results and intermediate clinical outcomes after multiple saphenous vein graft stenting. J Am Coll Cardiol. 2000; 35: 389–397.[Abstract/Free Full Text]

13. Tsui JC, Souza DS, Filbey D, et al. Preserved endothelial integrity and nitric oxide synthase in saphenous vein grafts harvested by a ‘no-touch’ technique. Br J Surg. 2001; 88: 1209–1215.[CrossRef][Medline] [Order article via Infotrieve]

14. Waksman R, Ajani AE, White RL, et al. Intravascular gamma radiation for in-stent restenosis in saphenous-vein bypass grafts. N Engl J Med. 2002; 346: 1194–1199.[Abstract/Free Full Text]

15. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary artery bypass fate and patient outcome: angiographic follow-up of 5065 grafts related to survival and reoperation in 1388 patients during 25 years. J Am Coll Cardiol. 1996; 28: 616–626.[Abstract]

16. Bourassa MG, Enjalbert M, Campeau L, et al. Progression of atherosclerosis in coronary arteries and bypass grafts: ten years later. Am J Cardiol. 1984; 53: 102C–107C.[CrossRef][Medline] [Order article via Infotrieve]

17. Wiklund L, Bugge M, Berglin E. Angiographic results after the use of a sutureless aortic connector for proximal vein graft anastomoses. Ann Thorac Surg. 2002; 73: 1993–1994.[Abstract/Free Full Text]

18. Calafiore AM, Bar-El Y, Vitolla G, et al. Early clinical experience with a new sutureless anastomotic device for proximal anastomosis of the saphenous vein to the aorta. J Thorac Cardiovasc Surg. 2001; 121: 854–858.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. D. Puskas, M. E. Halkos, H. Balkhy, M. Caskey, M. Connolly, J. Crouch, A. Diegeler, J. Gummert, W. Harringer, V. Subramanian, et al.
Evaluation of the PAS-Port Proximal Anastomosis System in coronary artery bypass surgery (the EPIC trial)
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 125 - 132.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
T. Puehler, S. Fraund-Cremer, J. Cremer, and A. Boening
Successful six-year follow-up of a sutureless device for proximal anastomoses in a severely calcified ascending aorta
Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 670 - 672.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Kempfert, U. T. Opfermann, M. Richter, T. Bossert, F. W. Mohr, and J. F. Gummert
Twelve-Month Patency With the PAS-Port Proximal Connector Device: A Single Center Prospective Randomized Trial
Ann. Thorac. Surg., May 1, 2008; 85(5): 1579 - 1584.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
W. J.L. Suyker and C. Borst
Coronary Connector Devices: Analysis of 1,469 Anastomoses in 1,216 Patients
Ann. Thorac. Surg., May 1, 2008; 85(5): 1828 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Bergmann, K. Meszaros, S. Huber, P. Oberwalder, H. Machler, G. Schaffler, R. Rienmueller, and B. Rigler
Forty-one-month follow-up of the Symmetry aortic connector system for proximal venous anastomosis
J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 23 - 28.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Biancari, J. Lahtinen, R. Ojala, L. Ahvenjarvi, A. Jartti, M. Mosorin, J. Heikkinen, P. Taskinen, and M. Lepojarvi
Spyder Aortic Connector System in Off-Pump Coronary Artery Bypass Surgery
Ann. Thorac. Surg., July 1, 2007; 84(1): 254 - 257.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. F. Gummert, S. Demertzis, K. Matschke, U. Kappert, M. Anssar, F. Siclari, V. Falk, E. L. Alderman, and W. Harringer
Six-Month Angiographic Follow-Up of the PAS-Port II Clinical Trial
Ann. Thorac. Surg., January 1, 2006; 81(1): 90 - 96.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
H. Kitamura, H. Okabayashi, M. Hanyu, Y. Soga, T. Nomoto, H. Johno, J. Nakano, T. Matsuo, M. Kai, and E. Umehara
Early and midterm patency of the proximal anastomoses of saphenous vein grafts made with a Symmetry Aortic Connector System
J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1028 - 1031.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Aoki, A. T.L. Ong, A. Hoye, L. A. van Herwerden, J. E. Sousa, A. Jatene, J. J.R.M. Bonnier, J. P.M.A. Schonberger, N. Buller, R. Bonser, et al.
Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial
Eur. Heart J., August 1, 2005; 26(15): 1488 - 1493.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
A. A. Frazier, F. Qureshi, K. M. Read, R. C. Gilkeson, R. S. Poston, and C. S. White
Coronary Artery Bypass Grafts: Assessment with Multidetector CT in the Early and Late Postoperative Settings
RadioGraphics, July 1, 2005; 25(4): 881 - 896.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Boening, F. Schoeneich, A. Lichtenberg, E. Bagaev, J. T. Cremer, and U. Klima
First clinical results with a 30{degrees} end-to-side coronary anastomosis coupler
Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 876 - 881.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Dietrich, S. Martens, M. Kohlert, C. Herzog, M. F. Khan, G. Wimmer-Greinecker, and A. Moritz
Decreased intermediate term patency of automated proximal anastomoses evaluated by sequential ultrafast CT
Eur. J. Cardiothorac. Surg., April 1, 2005; 27(4): 579 - 583.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
L. Wiklund, L.F. Bonilla, and E. Berglin
A new mechanical connector for distal coronary artery anastomoses in coronary artery bypass grafting: A randomized, controlled study
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 146 - 150.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
K. Matschke, U. Kappert, and J. Schneider
Graft Occlusion After Deployment of the Aortic Connector Symmetry System: Is Anticoagulation a Necessity?
Ann. Thorac. Surg., November 1, 2004; 78(5): 1878 - 1878.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. Reuthebuch, A. Kadner, and M. I. Turina
Reply
Ann. Thorac. Surg., November 1, 2004; 78(5): 1878 - 1879.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
B. Medalion, D. Meirson, E. Hauptman, L. Sasson, and A. Schachner
Initial experience with the Heartstring proximal anastomotic system
J. Thorac. Cardiovasc. Surg., August 1, 2004; 128(2): 273 - 277.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Redaelli, F. Maisano, G. Ligorio, E. Cattaneo, F.M. Montevecchi, and O. Alfieri
Flow dynamics of the St Jude Medical Symmetry aortic connector vein graft anastomosis do not contribute to the risk of acute thrombosis
J. Thorac. Cardiovasc. Surg., July 1, 2004; 128(1): 117 - 123.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
F. Farhat, L. Chalabreysse, C. Diab, S. Aubert, and O. Jegaden
Histological aspects of the saphenous vein damage with the use of the symmetry(R) aortic connector system
Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 373 - 375.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Martens, M. Dietrich, C. Herzog, M. Doss, G. Schneider, A. Moritz, and G. Wimmer-Greinecker
Automatic connector devices for proximal anastomoses do not decrease embolic debris compared with conventional anastomoses in CABG
Eur. J. Cardiothorac. Surg., June 1, 2004; 25(6): 993 - 1000.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
K. Okada, T. Sueda, K. Orihashi, and K. Imai
Early type A dissection with the aortic connector device
Eur. J. Cardiothorac. Surg., May 1, 2004; 25(5): 902 - 904.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. J. Cavendish, W. F. Penny, M. M. Madani, S. Keramati, O. Ben-Yehuda, D. G. Blanchard, E. Mahmud, A. Perricone, and S. Tsimikas
Severe ostial saphenous vein graft disease leading to acute coronary syndromes following proximal aorto-saphenous anastomoses with the symmetry bypass connector device: Is it a suture device or a "stent"?
J. Am. Coll. Cardiol., January 7, 2004; 43(1): 133 - 139.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/4/452    most recent
01.CIR.0000080916.84077.C0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Traverse, J. H.
Right arrow Articles by Emery, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Traverse, J. H.
Right arrow Articles by Emery, R. W.
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary interventions: stents
Right arrow CV surgery: coronary artery disease